Parkinson's disease is an heterogeneous disorder;Hétérogénéité de la maladie de Parkinson

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 2, 2003, Pages 259-276

  Vidailhet, Marie ^a   Henrion, Roger ^b   Bégué, Pierre ^b   Hauw, Jean Jacques ^b   Gautier, Jean Claude ^b   Laccourreye, Henri ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

Lewy bodies; Multiple system atrophy; Parkinson disease; Parlin protein; Supranuclear palsy, progressive; Synuclein

Indexed keywords

DIAGNOSTIC PROCEDURE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; GENETIC HETEROGENEITY; HEREDITY; HUMAN; PARKINSON DISEASE; REVIEW; STRUCTURE ANALYSIS; ARTICLE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME;

NERVE PROTEIN; PARKIN; SYNUCLEIN; TAU PROTEIN; UBIQUITIN PROTEIN LIGASE;

DIAGNOSIS, DIFFERENTIAL; GENETIC HETEROGENEITY; HUMANS; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNUCLEINS; TAU PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0642367300     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34048-8     Document Type: Review

References (81)

1. ELBAZ A., GRIGOLETTO F., BALDERESCHI M. et al. - Familial aggregation of Parkinson's disease : a population-based case-control study in Europe. Europarkinson Study Group. Neurology, 1999, 52, 1876-1882.
2. HUGHES A.J., DANIEL S.E., KILFORD L., LEES A.J. - Accuracy of clinical diagnosis of idiopathic Parkinson's disease, a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55, 181-184.
3. HUGUES A.J., BEN-SCHLOMO Y., DANIEL S.E., LEES A.J. - What features improve the accuracy of clinical diagnosis in Parkinson's disease, a clinicopathological study. Neurology, 1992, 42, 1142-1146.
4. HUGUES A.J., DANIEL S.E., LEES A.J. - Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology, 2001, 5, 1497-1499.
5. GWINN-HARDY K. - Genetics of Parkinson. Mov Disord, 2002, 17, 645-656.
6. MICHEL P.P., HIRSH E., AGID A. - Maladie de Parkinson, mécanismes de la mort cellulaire. Rev Neurol (Paris), 2002, 158, 7S24-7S32.
7. BROUSSOLLE E., THOBOIS S. - Génétique et facteurs environnementaux de la maladie de Parkinson. Rev Neurol (Paris), 2002, 158, 7S11-7S23.
8. MOURADIAN M.M. - Recent advances in the genetics and pathogenesis of Parkinson's disease. Neurology, 2002, 58, 179-185.
9. POLYMEROPOULOS M.H., LAVEDAN C., LEROY E. et al. - Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1991, 276, 2045-2047.
10. BOSTANTJOPOULOU S., KATSAROU Z., PAPADIMITRIOU A., VELETZA V., HATZIGEORGIOU G., LEES A. - Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Mov Disord, 2001, 16, 1007-1013.
11. GASSER T., MULLER-MYHSOK B., WSZOLEK Z.K et al. - A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet, 1998, 18, 262-265.
12. LEROY E., BOYER R., AUBURGER G. et al. - The ubiquitin pathway in Parkinson's disease. Nature, 1998, 395, 451-452.
13. FARRER M., GWINN-HARDY K., MUENTER M. et al. - Chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. J. Hum Mol Genet, 1999, 8, 81-85.
14. KITADA T., ASAKAWA S., HATTORI N. et al. - Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392, 605-608.
15. LUCKING C.B., DURR A., BONIFATI V. et al. - Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med, 2000, 342, 1560-1567.
16. VAN DE WARRENBURG B.P., LAMMENS M., LUCKING C.B. et al. - Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology, 2001, 56, 555-557.
17. HAYASHI S., WAKABAYASHI K., ISHIKAWA A. et al. - An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord, 2000, 15, 884-888.
18. FARRER M., CHAN P., CHEN R., TAN L. et al. - Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol, 2001, 50, 293-300.
19. WEST A., PERIQUET M., LINCOLN S. et al. - Complex relationship between Parkin mutations and Parkinson disease. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet, 2002, 114, 584-591.
20. VALENTE E.M., BENTIVOGLIO A.R., DIXON PH. et al. - Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet, 2001, 68, 895-900.
21. VAN DUIJN C.M., DEKKER M.C., BONIFATI V. et al. - Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet, 2001, 69, 629-634.
22. BONIFATI V., RIZZU P., VAN BAREN M.J. et al. - Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism. Science, 2003, 299, 256-259.
23. HICKS A., PETURSSON H., JOHNSSON T. - A susceptibility gene for late-onset idiopathic Parkinson's disease successfully mapped. Am J Hum Genet, 2001, 69, 200.
24. 18F-dopa PET study. Ann Neurol, 2002, 52, 849-853.
25. FUNAYAMA M., HASEGAWA K., KOWA H., SAITO M., TSUJI S., OBATA F. - A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol, 2002, 51, 296-301.
26. HICKS A.A., PETURSSON H., JONSSON T et al. - A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol, 2002, 52, 549-555.
27. GALVIN J.E., LEE V.M., TROJANOWSKI J.Q. - Synucleinopathies, clinical and pathological implications. Arch Neurol, 2001, 58, 186-190.
28. MCKEITH I.G., GALASKO D., KOSAKA K. et al. - Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB), report of the consortium on DLB international workshop. Neurology, 1996, 47, 1113-1124.
29. MCKEITH I.G., PERRY E.K., PERRY R.H. - Report of the second dementia with Lewy body international workshop, diagnosis and treatment. Consortium on dementia with Lewy bodies. Neurology, 1999, 53, 902-905.
30. VERNY M., DYUCKAERTS C. - Démence à corps de Lewy. Ann Méd Interne, 1998, 149, 209-215.
31. VERGHESE J., CRYSTAL H.A., DICKSON D.W., LIPTON R.B. - Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology, 1999, 53, 1974-1982.
32. MCKEITH I., DEL SER T., SPANO P. et al. - Efficacy of rivastigmine in dementia with Lewy bodies, a randomised, double-blind, placebo-controlled international study. Lancet, 2000, 356, 2031-2036.
33. ZESIEWICZ T.A., BAKER M.J., DUNNE P.B., HAUSER R.A. - Diffuse Lewy Body Disease. Curr Treat Options Neurol, 2001, 3, 507-518.
34. MINOSHIMA S., FOSTER N.L., SIMA A.A., FREY K.A., ALBIN R.L., KUHL D.E. - Alzheimer's disease versus dementia with Lewy bodies, cerebral metabolic distinction with autopsy confirmation. Ann Neurol, 2001, 50, 358-365.
35. LOBOTESIS K., FENWICK J.D., PHIPPS A. et al. - Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 2001, 56, 643-649.
36. WALKER Z., COSTA D.C., WALKER R.W.H. et al. - Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand J. Neurol. Neurosurg. Psychiatry, 2002, 73, 134-140.
37. [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry, 2001, 71, 583-588.
38. YOSHITA M., TAKI J., YAMADA M. - Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 metaiodobenzylguanidine myocardial scintigraphy. J Neurol Sci, 1998, 155, 60-67.
39. LITVAN I., MACINTYRE A., GOEZ G.C. et al. - Accuracy of the clinical diagnosis of Lewy body disease, Parkinson's disease, and dementia with Lewy bodies, a clinico-pathologic study. Arch Neurol, 1998, 55, 969-978.
40. GRAHAM J.G., OPPENHEIMER D.R. - Orthostatic hypotension and nocotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry, 1969, 32, 28-34.
41. BEN-SHLOMO Y., WENNING G.K., TISON F., QUINN N.P. - Survival of patients with pathologically proven multiple system atrophy, a meta-analysis. Neurology, 1997, 48, 384-393.
42. SCHRAG A., BEN-SHLOMO Y., QUINN N.P. - Prevalence of progressive supranuclear palsy and multiple system atrophy, a cross-sectional study. Lancet, 1999, 354, 1771-1775.
43. WENNING G.K., BEN SHLOMO Y., MAGALHAES M., DANIEL S.E., QUINN N.P. - Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain, 1994, 117, 835-845.
44. VIDAILHET M., BONNET A.M., AGID Y. - Critères cliniques et diagnostiques des atrophies multisystématisées. Rev Neurol (Paris), 1998, 154, 17-21.
45. TISON F. - Evolution des critères cliniques du diagnostic d'atrophie multisystématisée. Rev Neurol (Paris), 2000, 156, 711-717.
46. ADAMS R.D., VAN BOGAERT L., VAN DER EECKEN H. - Dégé nérescence nigro-striées et cérébello-nigro- striées. Psychiatria Neurologia, 1961, 142, 219-259.
47. DÉJERINE J., THOMAS A.A. - L'atrophie olivo-ponto- cérébelleuse. Nouv. Iconogr. Salpêtrière, 1890, 13, 330-370.
48. SHY G.M., DRAGER GA. - A neurologic syndrome associated with orthostatic hypotension. Arch. Neurol, 1960, 2, 511-527.
49. COSTA C., DUYCKAERTS C., CERVERA P., HAUW J.J. - Les inclusions oligodendrogliales, un marqueur des atrophies multsystématisées. Rev. Neurol (Paris), 1992, 148, 274-280.
50. DICKSON D.W., LIN W, LIU W.K., YEN S.H. - Multiple system atrophy, a sporadic synucleinopathy. Brain Pathol, 1999, 9, 721-732.
51. GILMAN S., LOW P.A., QUINN N. et al. - Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci, 1999, 163, 94-8.
52. LITVAN I., GOETZ C.G., JANKOVIC I, et al. - What is the accuracy of the clinical diagnosis of multiple system atrophy ? A clinicopathologic study. Arch. Neurol, 1997, 54, 937-944.
53. WATANABE H., SAITO Y., TERAO S. et al. - Progression and prognosis in multiple system atrophy, an analysis of 230 Japanese patients. Brain, 2002, 125, 1070-1083.
54. WENNING G.K., TISON F., BEN SHLOMO Y., DANIEL S.E., QUINN N.P. - Multiple system atrophy, a review of 203 pathologically proven cases. Mov. Disord, 1991, 12, 133-147.
55. BONNET A.M., PICHON J., VIDAILHET M. et al. - Urinary disturbances in striatonigral degeneration and Parkinson's disease, clinical and urodynamic aspects. Mov. Disord, 1997, 12, 509-513.
56. ARVANATAKIS Z., WSZOLEK Z.K. - Recent advances in the understanding of tau protein movment disorders. Curr Opin Neurol, 2001, 14, 491-497.
57. STEELE J.C., RICHARDSON R., OLSZWESKI J. - Progressive supranuclear palsy. Arch Neurol, 1964, 10, 333-359.
58. PASTOR P., TOLOSA E. - Progressive supranuclear palsy, clinical and genetic aspects. Curr Opin Neurol, 2002, 15, 429-437.
59. NATH U., BEN-SHLOMO Y., THOMSON R.G. et al. - The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain, 2001, 124, 1438-1449.
60. KOMORI T. - Tau positive glial incusions in progressive supranucear palsy, corticobasal degeneration and Pick's disease. Brain pathology, 1999, 9, 663-679.
61. LITVAN I., CAMPBELL G., MANGONE C.A. et al. - Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders ? A clinicopathological study. Brain, 1997, 120, 65-74.
62. ROJO A., PERNAUTE R.S., FONTAN A. et al. - Clinical genetics of familial progressive supranuclear palsy. Brain, 1999, 122, 1233-1245.
63. PILLON B., DUBOIS B., AGID Y. - Testing cognition may contribute to the diagnosis of movement disorders. Neurology, 1996, 46, 329-334.
64. DANIEL S.E., DE B. V, LEES A.J. - The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), a reappraisal. Brain, 1995, 118, 759-770.
65. LITVAN I., AGID Y., JANKOVIC J. et al. - Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olzsewski syndrome). Neurology, 1996, 46, 922-930.
66. LITVAN I., AGID Y., CALNE D. et al. - Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome), report of the NINDS-SPSP international workshop. Neurology, 1996, 47, 1-9.
67. BARCLAY C.L., LANG A.E. - Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 1997, 62, 352-356.
68. REBEIZ J.J., KOLODNY E.H., RICHARDSON R. - Corticodentatonigral degeneration with nueronal achromasia. Arch. Neurol, 1968, 18, 20-33.
69. WENNING G.K., LITVAN I., JANKOVIC J., et al. - Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J. Neurol. Neurosurg. Psychiatry, 1998, 64, 184-189.
70. LITVAN I., AGID Y., GOETZ C., et al. - Accuracy of the clinical diagnosis of corticobasal degeneration, a clinicopathologic study. Neurology, 1997, 48, 119-125.
71. BERGERON C., POLLANEN M.S., WEYER L., BLACK S.E., LANG A.E. - Unusual clinical presentations of cortico-basal ganglionic degeneration. Ann. Neurol, 1996, 40, 893-900.
72. BERGERON C., DAVIS A., LANG A.E. - Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol, 1998, 8, 355-365.
73. KASHMERE J., CAMICIOLI R., MARTIN W. - Parkinsonian syndromes and differential diagnosis. Curr Opin Neurol, 2002, 15, 461-466.
74. KRAFT E., SCHWARZ J., TRENKWALDER C., VOGL T., PFLUGER T., OERTEL W.H. - The combination of hypointense and hyperintense signal changes on T2 - weighted magnetic resonance imaging sequences, a specific marker of multiple system atrophy ? Arch Neurol, 1999, 56, 225-228.
75. BHATTACHARYA K., SAADIA D., EISENKRAFT B. et al. - Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease, a diagnostic algorithm. Arch Neurol, 2002, 5, 835-842.
76. BROUSSOLLE E., VERIN M. - Apport de l'IRM pour le diagnostic de l'atrophie multisystématisée. Rev Neurol (Paris), 2002, 158, 1243-1245.
77. SAKAKIBARA R., HATTORI T., UCHIYAMA T., YAMANISHI T. - Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry, 2001, 71, 600-606.
78. VODUSEK D.B. - Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord, 2001, 16, 600-607.
79. LEIGH R.J., RILEY D.E. - Eye movements in parkinsonism, it's saccadic speed that counts. Neurology, 2000, 54, 1018-1019.
80. VIDAILHET M., RIVAUD S., GOUIDER-KHOUJA N. et al. - Eye movements in parkinsonian syndromes. Ann Neurol, 1994, 35, 420-426.
81. RIVAUD-PECHOUX S., VIDAILHET M., GALLOUEDEC G., LITVAN I., GAYMARD B., PIERROT-DESEILLIGNY C. - Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology, 2000, 54, 1029-1032.